PS
Pradeep Shanthilal
About Pradeep Shanthilal
Data last updated:
Pradeep Shanthilal is a Director at Mediscribe (India) Private Limited (since 1999) and Director at Atria Clinical Research India Private Limited (since 2017). The companies operate in Business Outsourcing and Research & Development. The 2 current companies with reported revenue have a combined latest revenue of ₹5.91 Cr; the largest is Mediscribe (India) Private Limited at ₹5.90 Cr (FY 2025). Earlier, Pradeep Shanthilal was a Director at Stenmed Health Services India Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Mar 1999 | 1999 | ₹5.90 Cr (FY 2025) | Active | |
| Director | 31 Aug 2017 | 2017 | ₹84,100 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Nov 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pradeep Shanthilal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kavitha Prakash | 03123743 | Mediscribe (India) Private Limited , Atria Clinical Research India Private Limited | Director |
| Prakash Shantilal | 00572626 | Mediscribe (India) Private Limited , Atria Clinical Research India Private Limited | Director |
| Rajani Bharat Tukol | 03123750 | Mediscribe (India) Private Limited | Director |
| Sudhirkumar Ambalal Patel | 08973646 | Atria Clinical Research India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pradeep Shanthilal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pradeep Shanthilal
Pradeep Shanthilal currently holds 2 directorships: Mediscribe (India) Private Limited (Director, since 22 Mar 1999, revenue ₹5.90 Cr (FY 2025)); Atria Clinical Research India Private Limited (Director, since 31 Aug 2017, revenue ₹84,100 (FY 2024)).
Pradeep Shanthilal was first appointed on 22 Mar 1999 as Director at Mediscribe (India) Private Limited. The most recent appointment on record is 31 Aug 2017 at Atria Clinical Research India Private Limited.
The 2 current companies of Pradeep Shanthilal that report revenue have a combined latest revenue of ₹5.91 Cr: Mediscribe (India) Private Limited ₹5.90 Cr (FY 2025); Atria Clinical Research India Private Limited ₹84,100 (FY 2024).
Pradeep Shanthilal held 1 earlier board appointment: Stenmed Health Services India Private Limited (Director, from 25 Nov 2009).
The current boards of Pradeep Shanthilal's companies include Kavitha Prakash (Mediscribe (India) Private Limited), Prakash Shantilal (Mediscribe (India) Private Limited), Rajani Bharat Tukol (Mediscribe (India) Private Limited), Sudhirkumar Ambalal Patel (Atria Clinical Research India Private Limited).